Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,816 public trials 1,781 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

NCT01740427

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +7 more
Locations
  • Southern California Permanente Medical Group Bellflower, California, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • St. Joseph Heritage Healthcare Fullerton, California, United States
  • Los Angeles Hematology/Oncology Medical Group Glendale, California, United States
View all 305 locations
View Trial Details
Completed

Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer

NCT03238196

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Baptist Memorial Hospital MEMPHIS Memphis, Tennessee, United States
View Trial Details
Completed

Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status

NCT02339532

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Institut de Cancerologie de L'Ouest - Site Paul Papin Angers, France
  • Centre Hospitalier Regional Universitaire de Brest - Hôpital Morvan Brest, France
  • Centre Francois Baclesse Caen, France
  • Centre Jean Perrin Clermont-Ferrand, France
View Trial Details
Completed

CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO

NCT03227328

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Negative Breast Cancer, +6 more
Locations
  • U.O. Oncologia Medica, P.O. Bellaria-Maggiore Bologna, BO, Italy
  • UO Oncologia Medica IRST IRCCS Meldola, FC, Italy
  • Dip. Medicina Interna e Riabilitazione - U.O. Medicina Interna Oncologica, Ospedale Ramazzini Carpi, MO, Italy
  • Dip. Oncologia-Ematologia - U.O. Oncologia Medica,Azienda USL di Piacenza - Ospedale Civile Piacenza, PC, Italy
View all 20 locations
View Trial Details

Related conditions